Abstract
MAGNAMYCIN hydrochloride is a new monobasic antibiotic possessing strong inhibitory activity predominantly against gram-positive bacteria. Preliminary tests on laboratory animals demonstrated that the drug exhibited low toxicity and did not exhibit cross resistance with other antibiotics in general use.¶ In vitro tests showed it to be highly effective against many gram-positive organisms, including enterococci and penicillin-resistant Micrococcus pyogenes (var. aureus), both of which are becoming increasingly difficult to eradicate.In this preliminary report, 15 patients with genitourinary infections were selected for treatment with Magnamycin because the majority had failed to respond to other antibiotics, including sulfonamides, penicillin, streptomycin, aureomycin, . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
